Β-乙酰基-Γ-O-十六烷基-L-Α-卵磷脂
Β-乙酰基-Γ-O-十六烷基-L-Α-卵磷脂 性质
| 熔点 | 247 °C |
|---|---|
| 储存条件 | -20°C |
| 溶解度 | 溶于水或乙醇 |
| 形态 | 冻干粉 |
| 水溶解性 | Soluble to 100 mM in water |
| BRN | 3574588 |
Β-乙酰基-Γ-O-十六烷基-L-Α-卵磷脂 用途与合成方法
|
Human Endogenous Metabolite
|
ERK
|
MEK
|
C16-PAF (PAF (C16); 0.5-1.5 μM; for 24 hours) elicits significant concentration-dependent neuronal loss in PAFR
−/−
but not PAFR
+/+
cultures. C16-PAF (1 μM) elicits neuronal death in PAFR
−/−
cells infected with EGFP alone.
C16-PAF (1 μM; for 24 hours) activates caspase 7 but not caspase 3 in PAFR
−/−
neurons.
C16-PAF is synthesized by two distinct pathways; the remodeling pathway and the de novo synthesis pathway. C16-PAF acts by binding to a unique G-protein-coupled seven transmembrane receptor.
C16-PAF (1-25 μg/ml; 6, 12, 24 h) inhibits
M. smegmatis
and
M. bovis
BCG growth in a time-dependent manner.
Cell Viability Assay
| Cell Line: | Cerebellar granule neurons (CGNs) from PAFR −/− and PAFR +/+ mice |
| Concentration: | 0.5-1.5 μM |
| Incubation Time: | 24 hours |
| Result: | Elicited significant concentration-dependent neuronal loss in PAFR −/− but not PAFR +/+ cultures in serum-free media. |
Western Blot Analysis
| Cell Line: | CGNs |
| Concentration: | 1 μM |
| Incubation Time: | 24 hours |
| Result: | Activated caspase 7 but not caspase 3 in PAFR −/− neurons. |
安全信息
| 危险品标志 | Xn |
|---|---|
| 危险类别码 | 22-38-40-48/20/22 |
| 安全说明 | 36/37-24/25-22 |
| 危险品运输编号 | UN 1888 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS号 | EC6060000 |
| F | 10-21 |
Β-乙酰基-Γ-O-十六烷基-L-Α-卵磷脂 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024-04-30 | HY-108635 | Β-乙酰基-Γ-O-十六烷基-L-Α-卵磷脂 | 74389-68-7 | 10mM * 1mLin DMSO | 1840 |
| 2024-04-30 | HY-108635 | Β-乙酰基-Γ-O-十六烷基-L-Α-卵磷脂 | 74389-68-7 | 10mg | 2800 |
